Manifestations and management of Sjögren's disease.

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsMM-F has nothing to report. LK was an investigator in the Prometheus study (supported by Institute of Rheumatology, Czech Republic) and has participated in an advisory board for BI. MK reports clinical research support from Boehringer Ingelheim. EDC reports a grant from the National Institutes of Health and royalties for writing from UpToDate. Competing interests MM-F has nothing to report. LK was an investigator in the Prometheus study (supported by Institute of Rheumatology, Czech Republic) and has participated in an advisory board for BI. MK reports clinical research support from Boehringer Ingelheim. EDC reports a grant from the National Institutes of Health and royalties for writing from UpToDate."

"Funding Writing support was provided by Elizabeth Ng and Wendy Morris of Fleishman-Hillard, London, UK, which was contracted and funded by Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim was given the opportunity to review the article for medical and scientific accuracy as well as intellectual property considerations."